Invention Grant
- Patent Title: Immunomodulators
-
Application No.: US14971352Application Date: 2015-12-16
-
Publication No.: US09944678B2Publication Date: 2018-04-17
- Inventor: Li-Qiang Sun , Qian Zhao , Eric P. Gillis , Michael Matthew Miller , Martin Patrick Allen , Eric Mull , Paul Michael Scola
- Applicant: BRISTOL-MYERS SQUIBB COMPANY
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agent Pamela A. Mingo
- Main IPC: C07K7/08
- IPC: C07K7/08 ; A61K38/10 ; A61K45/06 ; C07K14/47 ; A61K38/00
Abstract:
The present disclosure provides novel macrocyclic peptides which inhibit the PD-1/PD-L1 and PD-L1/CD80 protein/protein interaction, and thus are useful for the amelioration of various diseases, including cancer and infectious diseases.
Public/Granted literature
- US20160176928A1 Immunomodulators Public/Granted day:2016-06-23
Information query
